Chelsea Counsel CO Abb Vie Inc. Transaction History

Chelsea Counsel CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 23, 2023	BUY	$138.31 - $165.87 $11,064 - $13,269	80 New	80 $12,000
Q4 2021 May 23, 2022	BUY	$107.43 - $135.93 $182,631 - $231,081	1,700 New	1,700 $230,000
Q3 2018 Dec 09, 2019	SELL	$88.91 - $98.84 $202,714 - $225,355	-2,280 Closed	0 $0
Q2 2018 Oct 03, 2018	SELL	$89.78 - $106.23 $8,978 - $10,623	-100 Reduced 4.2%	2,280 $211,000
Q3 2017 Jan 12, 2018	SELL	$69.85 - $89.22 $55,879 - $71,376	-800 Reduced 25.16%	2,380 $211,000
Q2 2017 Jan 22, 2018	BUY	N/A	3,180	3,180 $231,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

Stay updated on Chelsea Counsel CO with notifications on news.